Most People Already Have Immune Defenses Against H5N1 Bird Flu: Journal ‘Immunity’
94% had H5 antibodies, 100% showed neutralization despite no exposure to virus.
A new peer-reviewed study published last week in the journal Immunity reports that the vast majority of people already carry antibodies capable of neutralizing the cattle-linked purported H5N1 bird flu virus, despite having no known exposure to H5N1 and being classified as immunologically naïve.
It also challenges the justification for government-led gain-of-function bird flu experiments and mass vaccine development programs built on the premise that humans have little to no existing immunity, including the Trump administration’s $500 million “next-generation, gold-standard” bird flu vaccine effort.
Bottom Line – The findings show that H5N1 is not entering the human population as an immunological blank slate: most people already carry antibodies and immune memory capable of recognizing and neutralizing the virus, even without prior exposure. This directly undercuts pandemic narratives that portray H5N1 as a wholly novel, population-wide threat requiring emergency gain-of-function research or mass vaccine programs to create immunity from scratch.
https://jonfleetwood.substack.com/p/most-people-already-have-immune-defenses?
AND
Pre-existing neutralizing antibodies against cattle-transmitted influenza A virus H5N1 are detectable in unexposed individuals
https://www.cell.com/immunity/fulltext/S1074-7613(25)00569-2?
which strain “hit” the ostrich farm?
according to the CFIA, sequencing of the ostrich viruses showed they belonged to H5N1 clade 2.3.4.4b genotype D1.3.
https://birdflustudies.com/h5n1-and-the-curious-case-of-canadian-ostriches/
These Ostriches were a THREAT to the international pharmaceutical industry and were callously disposed of before they could impact the next generation of injections.
Imo — this situation was about MONEY and had little or nothing to do with safety for humans. Viable alternatives were presented to and rejected by Canadian authorities.
It will take decades to replace these research participants — I’ve no doubt that champagne flowed in the boardrooms of the vax industry.